[1] 王常鹤,朱璇,邓静,等. 超声剪切波弹性成像联合AAR、APRI和FIB-4指数诊断慢性乙型肝炎患者肝纤维化程度效能研究. 实用肝脏病杂志,2025,28(1):32-35. [2] Yang X, Li Q, Liu W, et al. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment. Cell Mol Immunol, 2023,20(6):583-599. [3] 王钰,刘洁,樊健敏,等. 超声声触诊弹性成像诊断慢性乙型肝炎患者肝纤维化价值研究. 实用肝脏病杂志,2025,28(3):342-345. [4] Qi RX, Jiang JS, Shao J, et al. Measurement of myocardial extracellular volume fraction in patients with heart failure with preserved ejection fraction using dual-energy computed tomography. Eur Radiol, 2022,32(6):4253-4263. [5] Kutaiba N, Tran A, Ashraf S, et al. Computed tomography-derived extracellular volume fraction and splenic size for liver fibrosis staging. J Comput Assist Tomogr, 2024,48(6):837-843. [6] Matuz-Mares D, Vázquez-Meza H, Vilchis-Landeros MM. NOX as a therapeutic target in liver disease. Antioxidants (Basel), 2022,11(10):2038. [7] Pavicic Saric J, Lulic D, Rogic D, et al. YKL-40 in virus-associated liver disease: a translational biomarker linking fibrosis, hepatocarcinogenesis, and liver transplantation. Int J Mol Sci, 2025,26(19):9584. [8] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2022年版).实用肝脏病杂志,2023,26(3)S18-39. [9] Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction:comparison with 99mTc-DTPA autoradiography in rats. Radiology, 1999,211(3):698-708. [10] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年). 实用肝脏病杂志,2019,22(6):793-803. [11] 毛垚耀,张家鸣,吕佩真,等. 寡糖链检测评估益气活血方联合抗病毒治疗乙型肝炎相关肝纤维化患者的疗效. 中华肝脏病杂志,2025,33(9):880-888.. [12] Yoon JH, Lee JM, Klotz E, et al. Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading. Invest Radiol, 2015,50(4):290-296. [13] Hong SJ, Kim JE, Cho JM, et al. Dual energy CT-derived liver extracellular volume fraction for assessing liver functional reserve in patients with liver cirrhosis. Medicina (Kaunas), 2025,61(9):1561. [14] Hong S, Kim JE, Cho JM, et al. Quantification of liver extracellular volume using dual-energy CT for ruling out high-risk varices in cirrhosis. Eur J Radiol, 2022,148:110151. [15] 刘雅妮,郭瑞芳,王欢,等. 氧化应激参与HF发生发展的研究进展. 肝脏,2023,28(6):724-727. [16] 荆小港,吴龙龙,汪嵘. NADPH氧化酶在肝脏缺血再灌注损伤中的研究进展. 中华医学杂志,2024,104(26):2467-2470. [17] Verma S, Ishteyaque S, Washimkar KR, et al. Mitochondrial-mediated nuclear remodeling and macrophage polarizations: a key switch from liver fibrosis to HCC progression. Exp Cell Res, 2024,434(1):113878. [18] 孔凡坤,王煊,常李军,等. YKL-40、GP73、LN、PⅢNP、ⅣC与慢性乙型肝炎病毒感染患者病情的关系. 中华医院感染学杂志,2025,35(8):1121-1125. [19] 周莹,陈娇,叶龙,等. CT测量肝外基质体积分数评估慢性乙型肝炎患者HF临床应用研究. 实用肝脏病杂志,2020,23(4):492-495. [20] 史佳伟,黄晶. 几丁质酶样蛋白40与HF的关系. 临床肝胆病杂志,2021,37(9):2203-2205. [21] Del Turco S, De Simone P, Ghinolfi D, et al. Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients. Arab J Gastroenterol, 2021,22(3):187-192. [22] Li H, Xu X, Yan T. Serum YKL-40 Levels as a non-invasive potential biomarker for liver fibrosis patients: a systematic review and meta-analysis. Iran J Public Health, 2025,54(5):939-950. |